본문 바로가기
KERD
논문KCI 등재

Development of a Novel Subunit Vaccine Targeting Fusobacterium nucleatum FomA Porin Based on In Silico Analysis

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류치의학

초록

Selecting an appropriate antigen with optimal immunogenicity and physicochemical properties is a pivotal factor to develop a protein based subunit vaccine. Despite rapid progress in modern molecular cloning and recombinant protein technology, there remains a huge challenge for purifying and using protein antigens rich in hydrophobic domains, such as membrane associated proteins. To overcome current limitations using hydrophobic proteins as vaccine antigens, we adopted in silico analyses which included bioinformatic prediction and sequence-based protein 3D structure modeling, to develop a novel periodontitis subunit vaccine against the outer membrane protein FomA of Fusobacterium nucleatum. To generate an optimal antigen candidate, we predicted hydrophilicity and B cell epitope parameter by querying to web-based databases, and designed a truncated FomA (tFomA) candidate with better solubility and preserved B cell epitopes. The truncated recombinant protein was engineered to expose epitopes on the surface through simulating amino acid sequence-based 3D folding in aqueous environment. The recombinant tFomA was further expressed and purified, and its immunological properties were evaluated. In the mice intranasal vaccination study, tFomA significantly induced antigen-specific IgG and sIgA responses in both systemic and oral-mucosal compartments, respectively. Our results testify that intelligent in silico designing of antigens provide amenable vaccine epitopes from hard-to-manufacture hydrophobic domain rich microbial antigens.

Abstract

Selecting an appropriate antigen with optimal immunogenicity and physicochemical properties is a pivotal factor to develop a protein based subunit vaccine. Despite rapid progress in modern molecular cloning and recombinant protein technology, there remains a huge challenge for purifying and using protein antigens rich in hydrophobic domains, such as membrane associated proteins. To overcome current limitations using hydrophobic proteins as vaccine antigens, we adopted in silico analyses which included bioinformatic prediction and sequence-based protein 3D structure modeling, to develop a novel periodontitis subunit vaccine against the outer membrane protein FomA of Fusobacterium nucleatum. To generate an optimal antigen candidate, we predicted hydrophilicity and B cell epitope parameter by querying to web-based databases, and designed a truncated FomA (tFomA) candidate with better solubility and preserved B cell epitopes. The truncated recombinant protein was engineered to expose epitopes on the surface through simulating amino acid sequence-based 3D folding in aqueous environment. The recombinant tFomA was further expressed and purified, and its immunological properties were evaluated. In the mice intranasal vaccination study, tFomA significantly induced antigen-specific IgG and sIgA responses in both systemic and oral-mucosal compartments, respectively. Our results testify that intelligent in silico designing of antigens provide amenable vaccine epitopes from hard-to-manufacture hydrophobic domain rich microbial antigens.

참고문헌 (43)

  1. Milligan GN, "Vaccinology: An Essential Guide", pp.2~32 (2015), John Wiley & Sons
  2. Dennis R. Burton, "Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design", Annual Review of Immunology, 34(1), pp.635~659 (2016), Annual Reviews[DOI]
  3. Hilary D. Marston, "Considerations for Developing a Zika Virus Vaccine", New England Journal of Medicine, 375(13), pp.1209~1212 (2016), New England Journal of Medicine (NEJM[DOI]
  4. Rupa Kanapathipillai, "Ebola Vaccine — An Urgent International Priority", New England Journal of Medicine, 371(24), pp.2249~2251 (2014), New England Journal of Medicine (NEJM[DOI]
  5. Kingston H.G. Mills, "Do we need a new vaccine to control the re-emergence of pertussis?", Trends in Microbiology, 22(2), pp.49~52 (2014), Elsevier BV[DOI]
  6. Marcela Henao-Tamayo, "The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis", PLOS ONE, 10(9), pp.e0136500~ (2015), Public Library of Science (PLoS)[DOI]
  7. Kamran Haq, "Immunosenescence: influenza vaccination and the elderly", Current Opinion in Immunology, 29, pp.38~42 (2014), Elsevier BV[DOI]
  8. Mangtani P, "Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials", Clin Infect Dis, 58, pp.470~480 (2014)[DOI]
  9. Iain L. C. Chapple, "Diabetes and periodontal diseases: consensus report of the Joint EFP", AAP Workshop on Periodontitis and Systemic Diseases, 2013, pp.84(4-s), S106~S112[DOI]
  10. Maurizio S. Tonetti, "Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP", AAP Workshop on Periodontitis and Systemic Diseases, 2013, pp.40, S24~S29[DOI]
  11. Meyer DH, "Oral pathogens : from dental plaque to cardiac disease", Curr Opin Microbiol, 1, pp.88~95 (1998)
  12. Tatsuji Nishihara, "Microbial etiology of periodontitis", Periodontology 2000, 36(1), pp.14~26 (2004), Wiley[DOI]
  13. Mark J. Pallen, "Bacterial pathogenomics", Nature, 449(7164), pp.835~842 (2007), Springer Nature[DOI]
  14. Aleksandar D. Kostic, "The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead", Gastroenterology, 146(6), pp.1489~1499 (2014), Elsevier BV[DOI]
  15. George Hajishengallis, "Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response", Trends in Immunology, 35(1), pp.3~11 (2014), Elsevier BV[DOI]
  16. Magda Feres, "The subgingival periodontal microbiota of the aging mouth", Periodontology 2000, 72(1), pp.30~53 (2016), Wiley[DOI]
  17. Timothy W. Hand, "Linking the Microbiota, Chronic Disease, and the Immune System", Trends in Endocrinology & Metabolism, 27(12), pp.831~843 (2016), Elsevier BV[DOI]
  18. Wu M, "A phylogenetic study of Fusobacterium nucleatum using the major outer membrane protein FomA", pp.2014
  19. Robert J. Palmer, "Interbacterial Adhesion Networks within Early Oral Biofilms of Single Human Hosts", Applied and Environmental Microbiology, 83(11), pp.00407~00417 (2017), American Society for Microbiology[DOI]
  20. Bolstad A, "Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum", Clin Microbiol Rev, 9, pp.55~71 (1996)
  21. Pei-Feng Liu, "Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis", Vaccine, 28(19), pp.3496~3505 (2010), Elsevier BV[DOI]
  22. Signat B, "Role of Fusobacterium nucleatum in periodontal health and disease", Curr Issues Mol Biol, 13, pp.25~36 (2011)
  23. Richard P. Darveau, "Periodontitis: a polymicrobial disruption of host homeostasis", Nature Reviews Microbiology, 8(7), pp.481~490 (2010), Springer Nature[DOI]
  24. Jan Holmgren, "Mucosal immunity and vaccines", Nature Medicine, 11(4s), pp.S45~S53 (2005), Springer Nature[DOI]
  25. Marian R. Neutra, "Mucosal vaccines: the promise and the challenge", Nature Reviews Immunology, 6(2), pp.148~158 (2006), Springer Nature[DOI]
  26. Seol Hee Hong, "Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection", Vaccine, 30(2), pp.466~474 (2012), Elsevier BV[DOI]
  27. Chung Truong Nguyen, "Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice", Vaccine, 29(34), pp.5731~5739 (2011), Elsevier BV[DOI]
  28. Puth S, "Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model", Hum Vaccin Immunother
  29. S. E. Lee, "A Bacterial Flagellin, Vibrio vulnificus FlaB, Has a Strong Mucosal Adjuvant Activity To Induce Protective Immunity", Infection and Immunity, 74(1), pp.694~702 (2005), American Society for Microbiology[DOI]
  30. Jae Sung Lim, "Flagellin-dependent TLR5", caveolin-1 as a promising immune activator in immunosenescence, 2015, pp.14(5), 907~915[DOI]
  31. 최은경, "Potentiation of Bacterial Killing Activity of Zinc Chloride by Pyrrolidine Dithiocarbamate", The Journal of Microbiology, 48(1), pp.40~43 (2010), 한국미생물학회
  32. Parker JM, "New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites", Biochemistry, 25, pp.5425~5432 (1986)
  33. Jens Larsen, "Improved method for predicting linear B-cell epitopes", Immunome Research, 2(1), pp.2~ (2006), Springer Nature[DOI]
  34. Julia V Ponomarenko, "Antibody-protein interactions: benchmark datasets and prediction tools evaluation", BMC Structural Biology, 7(1), pp.64~ (2007), Springer Nature[DOI]
  35. Lawrence A Kelley, "The Phyre2 web portal for protein modeling, prediction and analysis", Nature Protocols, 10(6), pp.845~858 (2015), Springer Nature[DOI]
  36. Andreas Demuth, "Pathogenomics: An updated European Research Agenda", Infection, Genetics and Evolution, 8(3), pp.386~393 (2008), Elsevier BV[DOI]
  37. 최점일, "Vaccines against periodontitis: a forward-looking review", Journal of Periodontal & Implant Science, 40(4), pp.153~163 (2010), 대한치주과학회
  38. Scott N. Peterson, "Functional expression of dental plaque microbiota", Frontiers in Cellular and Infection Microbiology, 4, pp.108~ (2014), Frontiers Media SA[DOI]
  39. Dimiter V. Dimitrov, "Systems approaches to computational modeling of the oral microbiome", Frontiers in Physiology, 4, pp.172~ (2013), Frontiers Media SA[DOI]
  40. P. Jorth, "Metatranscriptomics of the Human Oral Microbiome during Health and Disease", mBio, 5(2), pp.e01012-14~e01012-14 (2014), American Society for Microbiology[DOI]
  41. Singhrao SK, "Oral inflammation, tooth loss, risk factors, and association with progression", J Alzheimers Dis, 42, pp.723~737 (2014)[DOI]
  42. Keum Jin Baek, "Association of the invasion ability of Porphyromonas gingivalis with the severity of periodontitis", Virulence, 6(3), pp.274~281 (2015), Informa UK Limited[DOI]
  43. Rafael Scaf de Molon, "Evaluation of the Host Response in Various Models of Induced Periodontal Disease in Mice", Journal of Periodontology, 85(3), pp.465~477 (2014), Wiley[DOI]

관련 논문AI추천

Production of Monoclonal Antibodies Specific to FimA of Porphyromonas gingivalis and Their Inhibitory Activity on Bacterial Binding김주, 고은미, 김태금, 이진영대한면역학회 · Immune Network2009 · 제9권 제5호Vaccines against periodontitis: a forward-looking review최점일, Gregory J. Seymour대한치주과학회 · Journal of Periodontal & Implant Science2010 · 제40권 제4호In Silico Subtractive Proteome Analysis to Design Multi-Epitope-Based Subunit Vaccine against Eikenella corrodensAlMalki Fatemah한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권 Immune Modulation of Recombinant OmpA against Brucella abortus 544 Infection in MiceAlisha Wehdnesday Bernardo Reyes, Hannah Leah Tadeja Simborio, Hong-hee Chang, Hu Jang Lee, Huynh Tan Hop, Jin Ju Lee, Lauren Togonon Arayan, Suk KIM, Wongi Min한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2016 · 제26권 제3호Antibody-based Screening of Porphyromonas gingivalis Proteins Specifically Produced in Patients with Chronic Periodontitis김혜정, 이석우대한구강생물학회 · International Journal of Oral Biology2018 · 제43권 제4호Characterization of the Salmonella typhi Outer Membrane Protein CAbolfazl Jahangiri, Hoda Toobak, Iraj Rasooli, Mohammadreza Jalali Nadoushan, Parviz Owlia, Seyed Latif Mousavi Gargari, Shakiba Darvish Alipour Astaneh한국미생물·생명공학회 · 한국미생물·생명공학회지2013 · 제41권 제1호

이 간행물의 다른 논문 (5건)